Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

NCT01315691 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Liposomal amikacin for inhalation
DRUG: Placebo for liposomal amikacin for inhalation

Sponsor

Insmed Incorporated